Text Size

Treatment Outcomes and Quality of Life After IMRT Treatments of Head and Neck Cancers

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Stanford University
ClinicalTrials.gov Identifier:
NCT00230256
First received: September 28, 2005
Last updated: July 11, 2012
Last verified: July 2012
History of Changes
  Purpose

The purpose of the research study is to evaluate effectiveness and the quality of life, specifically the risk of dry mouth, after radiation treatment for head and neck cancers.


Condition
Head and Neck Cancer

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: Treatment Outcomes and Quality of Life After IMRT Treatments of Head and Neck Cancers

Resource links provided by NLM:

U.S. FDA Resources

Further study details as provided by Stanford University:

Enrollment: 61
Study Start Date: April 2003
Study Completion Date: December 2008
Primary Completion Date: December 2008 (Final data collection date for primary outcome measure)
  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

Patients who complete radiation therapy for H&N cancers at Stanford University

Criteria

Inclusion Criteria:Patients who complete radiation therapy for H&N cancers at Stanford University

  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00230256

Locations
United States, California
Stanford University School of Medicine
Stanford, California, United States, 94305
Sponsors and Collaborators
Stanford University
Investigators
Principal Investigator: Quynh-Thu Le Stanford University
  More Information

No publications provided

Responsible Party: Stanford University
ClinicalTrials.gov Identifier: NCT00230256     History of Changes
Other Study ID Numbers: ENT0003, ENT0003, 79057
Study First Received: September 28, 2005
Last Updated: July 11, 2012
Health Authority: United States: Institutional Review Board

Additional relevant MeSH terms:
Head and Neck Neoplasms
Neoplasms by Site
Neoplasms

ClinicalTrials.gov processed this record on May 19, 2013